Orion Porfolio Solutions, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1360533 OMAHA, NE

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,692,278

+$387,204 QoQ

Shares Held

15,254

-11.3% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#176

of 466 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 29% Shared 0% None 71%

Healthcare · as of Jun 30, 2026

Orion Porfolio Solutions, LLC holds $26,666,840 across 17 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	123,571	$5,070,118
2	NBIX	Neurocrine Biosciences Inc	26,926	$4,538,108
3	HLN	Haleon plc	478,177	$4,461,391
4	UTHR	UNITED THERAPEUTICS Corp	4,176	$2,262,682
5	TAK	Takeda Pharmaceutical Co Ltd	110,838	$1,776,733
6	LNTH	Lantheus Holdings, Inc. This page	15,254	$1,692,278
7	ELAN	Elanco Animal Health Inc	52,791	$1,299,186
8	KNSA	Kiniksa Pharmaceuticals International, plc	17,775	$1,136,711

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,692,278	15,254	-11.3%	Shares	Sole	2026-08-14
2026-03-31	$1,305,074	17,206	+21.4%	Shares	Sole	2026-05-13
2025-12-31	$942,880	14,168	+55.8%	Shares	Sole	2026-02-12
2025-09-30	$466,482	9,095	-9.1%	Shares	Sole	2025-11-12
2025-06-30	$819,418	10,010	+3.9%	Shares	Sole	2025-08-27
2025-03-31	$940,180	9,633	+1.9%	Shares	Sole	2025-08-01
2024-12-31	$846,112	9,458	-8.1%	Shares	Sole	2025-08-01
2024-09-30	$1,129,437	10,291	+17.2%	Shares	Sole	2025-07-31
2024-06-30	$705,187	8,783	-6.3%	Shares	Sole	2025-07-31
2024-03-31	$583,562	9,376	-43.4%	Shares	Sole	2025-07-31
2023-12-31	$1,027,836	16,578	-29.0%	Shares	Sole	2025-07-31
2023-09-30	$1,622,566	23,353	+83.6%	Shares	Sole	2025-07-31
2023-06-30	$1,067,546	12,721	-0.6%	Shares	Sole	2025-07-31
2023-03-31	$1,056,107	12,792	—	Shares	Sole	2025-07-31
No filing history on record for this holder in this stock.